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Background: A number of neurological and neurodegenerative diseases share impaired cognition as a
common symptom. Therefore, the development of clinically applicable therapies to enhance cognition
has yielded signiﬁcant interest. Previously, we have shown that activation of lysophosphatidic acid re-
ceptors (LPARs) via gintonin application potentiates synaptic transmission by the blockade of Kþ chan-
nels in the mature hippocampus. However, whether gintonin may exert any beneﬁcial impact directly on
cognition at the neural circuitry level and the behavioral level has not been investigated.
Methods: In the current study, we took advantage of gintonin, a novel LPAR agonist, to investigate the
effect of gintonin-mediated LPAR activation on cognitive performances. Hippocampus-dependent fear
memory test, synaptic plasticity in the hippocampal brain slices, and quantitative analysis on synaptic
plasticity-related proteins were used.
Results: Daily oral administration of gintonin for 1 wk signiﬁcantly improved fear memory retention in
the contextual fear-conditioning test in mice. We also found that oral administration of gintonin for 1 wk
increased the expression of learning and memory-related proteins such as phosphorylated cyclic
adenosine monophosphate-response element binding (CREB) protein and brain-derived neurotrophic
factor (BDNF). In addition, prolonged gintonin administration enhanced long-term potentiation in the
hippocampus.
Conclusion: Our observations suggest that the systemic gintonin administration could successfully
improve contextual memory formation at the molecular and synaptic levels as well as the behavioral
level. Therefore, oral administration of gintonin may serve as an effective noninvasive, nonsurgical
method of enhancing cognitive functions.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cognitive enhancement has yielded signiﬁcant interest as dis-
rupted learning and memory is one of several widely shared deﬁ-
cits found inmany neurological and neurodegenerative diseases. So
far, a few manipulations have been proposed to enhance cognitive
function [1]. Lysophosphatidic acids (LPAs) are extracellular phos-
pholipidic molecules that bind to G-protein coupled LPA receptors
(LPARs) [2]. LPARs-associated signaling plays a number of roles inciences, Konkuk University, 120 N
ht  2015, The Korean Society of G
c-nd/4.0/).the early development of central nervous system [3]. Recent studies
have revealed that activation of LPARs in adult brain exerts a sig-
niﬁcant role in intellectual processing. For example, a study using
intrahippocampal LPA infusion to activate Rho pathway showed
enhanced long-term spatial memory in water maze test [4]. These
studies suggest that the activation of LPARs could contribute to
enhanced cognitive performances.
Recently, we have shown that a newly identiﬁed active
component of ginseng, gintonin, enhances synaptic transmission ineungdong-ro, Gwangjin-gu, Seoul, 143-701, South Korea.
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
Fig. 1. Gintonin enhances contextual fear memory. (A) Experimental scheme. (B) On
the testing day of fear conditioning task, freezing levels in vehicle or gintonin
administered mice were quantiﬁed. The gintonin-administered mice (n ¼ 8) showed
an increased fear memory retention when compared with vehicle-administered mice
(n ¼ 7, *p < 0.05) whereas there is no difference in basal anxiety (p > 0.4). Error bars
represent standard error of the mean. n.s., not signiﬁcant.
J Ginseng Res 2016;40:55e6156mature hippocampal synapses via the activation of LPARs [5].
Gintonin, a subset of glycolipoproteins, consists of LPAs and other
protein complexes with highly abundant acidic amino acids [6,7].
Recent investigations suggest that gintonin is a potential candidate
to mediate the beneﬁcial actions of ginseng [8]. Previous studies
showed that the application of gintonin induces a transient Ca2þ
increase through the binding of LPARs (LPAR1-6) in oocytes prep-
aration [6,9]. We have shown that gintonin-mediated LPAR acti-
vation increases the neuronal excitability and slightly depolarizes
the resting membrane potential of the hippocampal pyramidal
neurons [5]. These observations strongly suggest that gintonin-
mediated LPAR activation possibly may modulate synaptic plas-
ticity and/or learning processes.
Here, we aimed to investigate the effect of systemic gintonin
administration on cognitive function. We administered gintonin
daily by oral gavage to mice for 7 d and evaluated their memory
employing the contextual fear-conditioning test. We also examined
whether chronic gintonin administration enhanced long-term
synaptic plasticity and accompanied by synaptic plasticity-related
proteins in the hippocampus.
2. Materials and methods
2.1. Study participants
Male DBA/2 mice (22e25 g) were used in all experiments
(Charles River, Gapyeong, Republic of Korea). Mice were 7 wks old
at the time of arrival and maintained for at least 1 wk before the
start of the experiments. Theywere housed in a controlled vivarium
on a 12-h light/dark cycle with controlled temperature (22  1C)
and humidity (50 10%). Theywere allowed free access to food and
water. Behavior testing was conducted during the light cycle.
Among strains of mice available, the DBA/2 mouse strain was
chosen due to their poor performance in the contextual fear con-
ditioning [10]. All experiments were approved by the Institutional
Animal Care and Use Committee of Konkuk University, Seoul, Korea
(KU14154).
2.2. Gintonin preparation
Gintonin was extracted from Panax ginseng without ginseng
saponin as previously described [7]. We used the similar median
effective dose (ED50) concentrations, that exerted LPA receptor
activation in Xenopus oocyte preparation in a previous study [7].
Crude gintonin was dissolved in vehicle solution for oral adminis-
tration at the concentration (50 mg/kg) that was previously shown
to have behavioral effect in vivo [5]. For acute treatment, gintonin
was dissolved in dimethyl sulfoxide (DMSO; ﬁnal concentration of
DMSO, 0.1%).
2.3. Administration of gintonin and experimental procedures
To test the effect of gintonin on cognitive function, mice were
randomly separated into two groups: vehicle (saline, n ¼ 8) and
gintonin (50mg/kg, n¼ 7). After 5 d of handling, vehicle or gintonin
was administered daily by oral gavage for 7 d. The experimenters
were blind to the administration condition. The mice were sacri-
ﬁced the day after the ﬁnal treatment; 30 min after the last testing
on the behavioral test (see Fig. 1).
2.4. Slice preparation
Seven-wk-old mice were sacriﬁced after daily oral administra-
tion of either vehicle or gintonin for electrophysiology recordings, 1
d after the ﬁnal treatment. Researchers were blind to theexperimental group of mice. Brain slices (350 mm) were prepared
with a microtome (VT 1000S, Leica, Nussloch, Germany) in ice-cold
sucrose cutting buffer (212mM sucrose, 3mM KCl, 26mM NaHCO3,
1.25mM NaHPO4, 7mM MgCl2, and 10mM glucose) bubbled with
95% O2/5% CO2 mixed gas. Brain slices are placed in a chamber
containing artiﬁcial cerebrospinal ﬂuid (aCSF: 1mM NaH2PO4,
26.2mM NaHCO3, 118mM NaCl, and 2.5mM KCl, and freshly added
11mM glucose, 2mM CaCl2, and 1mM MgCl2) and recovered in a
35C water bath for 1 h, after which they were maintained at room
temperature. Temperature was maintained between 31C and 33C
during recording. For acute gintonin experiments, brain slices were
incubated with 3 mg/mL concentration of gintonin, which we have
shown to induce rapid, LPAR-dependent synaptic enhancement.
2.5. Electrophysiology
Field excitatory postsynaptic potentials (fEPSPs) were recorded
in CA1 dendrites using glass pipettes (0.5e1.5 MU) ﬁlled with aCSF
with two bipolar stimulating electrodes being placed in the strat-
ium radiatum. fEPSPs were alternately evoked through each bipolar
electrode with 30-s intervals. Theta burst stimulation (TBS, 20
bursts of 4 pulses at 100 Hz) was delivered at one pathway to
induce LTP while the other pathway remained unstimulated during
the TBS stimulation.
2.6. Behavioral apparatus
The contextual fear-conditioning task was carried out in square
chambers (17.78 cm W  17.78 cm D  30.48 cm H, Coulbourn
Instruments, Allentown, PA, USA). The chamber was equipped with
a grid ﬂoor that transmits a foot shock during training. The chamber
was surrounded with soundproofed shells and a ventilation fan
provided background noise. The foot shock was generated via a
Coulbourn programmable tone generator (model #A69-20; Coul-
bourn Instruments). The stimulus was controlled by Coulbourn
Graphic State software (Coulbourn Instruments). The chamber was
cleaned with 70% alcohol before and after each trial.
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The learning procedures consisted of three stages: (1) pre-
exposure, which allowed the mice to adapt the training chamber,
(2) training, during which the mice were exposed to foot shocks,
and (3) testing, in which mice responded to the context and
freezing behaviors were measured. Each phase was conducted at
24-h intervals. On the ﬁrst day of contextual fear conditioning
(preexposure), mice were placed into the chamber for 12 min. On
the training day, mice were placed into the same chamber, and
allowed to adapt for 148 s. Following this, the mice received a 2-s,
0.75 mA shock for three trials, with an intertrial interval of 30 s. On
the testing day, mice were placed in the training chamber and
allowed to move freely for 3 min. Fear memory was assessed by
measuring the freezing behavior of the mice. Freezing behavior was
deﬁned as the absence of any movement, except for breathing. The
percentage of time spent freezing was observed every 2 s by a
trained observer [11].
2.8. Western blot analysis
Thirty min after testing on the contextual fear-conditioning test,
all mice were sacriﬁced; the hippocampus was dissected and snap-
frozen in dry ice, and stored at80C before processing for analysis
by Western blot. The hippocampus was homogenized in ice-cold
buffer containing 20mM Tris (pH 7.5), 5% glycerol, 1.5mM EDTA,
40mM KCl, 0.5mM dithiothreitol, and protease inhibitors (539131,
Calbiochem). Homogenates were centrifuged at 14,000 g for 1 h at
4C. The supernatant was collected and protein concentration was
determined using the Bradford assay [12]. The proteins were
separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and transferred to polyvinylidene ﬂuoride membranes.
The membranes were blocked for 1 h in 5% skimmed milk in Tris-
buffered saline containing Tween-20 and then incubated with
primary antibodies against cyclic adenosine monophosphate-
response element binding protein (CREB; 1:1,000, Cell Signaling
Technology, Danvers, MA, USA), phospho-CREB (1:2,000, Millipore,
Darmstadt, Germany), brain-derived neurotrophic factor (BDNF)
(1:500, Santa Cruz biotechnology, Santa Cruz, CA, USA), and b-Actin
(1:5,000, Sigma, St. Louis, MO, USA). Following this, membranes
were incubated with the antirabbit immunoglobulin G (IgG)
horseradish-peroxidase-conjugated secondary antibodies (1:2,000,
Cell Signaling Technology, Danvers, MA, USA) or antimouse IgG
antibody (1:5,000, Millipore, Darmstadt, Germany). The protein
bands were immunodetected using an enhanced chem-
iluminescence kit (GE Healthcare, St. Giles, UK) and detected on an
X-ray ﬁlm. The bands were quantiﬁed by densitometry scanning
using the Image Gauge program (Fuji Film, Tokyo, Japan).
2.9. Statistical analysis
All data are presented as the mean  standard deviation. Two-
tailed unpaired t tests were used for statistical comparisons using
built-in data analysis tool pack in Microsoft Ofﬁce Excel 2007. A p
value < 0.05 was considered signiﬁcant.
3. Results
3.1. DBA/2 mice show better retention of fear memory after oral
administration of gintonin
To investigate whether LPAR activation via systemic gintonin
delivery could contribute to hippocampal memory formation, we
assessed contextual fear conditioning, a well-known hippocampal-
dependent learning procedure in DBA/2 mice after daily oraladministration of vehicle or gintonin for 1 wk (50 mg/kg, Fig. 1A)
[13]. Animals were exposed to an unfamiliar context (CS) with foot
shocks (US) during training on Day 2. Fear memory was tested 24 h
later by observing freezing behavior for 3 min when animals are
exposed to CS only. The overall freezing of gintonin-administered
mice was signiﬁcantly higher than the vehicle-administered mice
(Fig. 1B, right, p < 0.05), suggesting that daily administration of
gintonin enhances hippocampal dependent contextual fear mem-
ory. The long-term administration of gintonin at a given dose seems
to have minimal effect on general health of animals. We observed
no difference in weight changes with chronic gintonin treatment
compared to vehicle treatment (saline group: 22.29  1.70 g; gin-
tonin group: 22.50  1.69 g, p > 0.8). In addition, there was no
difference in freezing between the two groups during preexposure
(Fig. 1B, left, p > 0.4), indicating that gintonin did not affect the
alertness of themice and that the gintonin itself was not anxiogenic
at the concentration we administered.
3.2. Gintonin administration enhances long-lasting synaptic
potentiation in the Schaffer collateral pathway
Next, we examined the effect of chronic oral administration of
gintonin on synaptic plasticity in the hippocampus. Acute hippo-
campal slices were prepared 24 h after 7 d administration of vehicle
or gintonin (50 mg/kg, Fig. 2A). The experimenter was blind to the
different drug groups. fEPSPs were measured in the CA1 dendritic
region, while stimulating the stratium radiatum region of CA1
(Fig. 2A). Theta-burst stimulation (TBS, 20 bursts of 4 pulses at
100 Hz, each 0.2 ms) was used to induce LTP. The rise slope and
amplitude of the fEPSPs was signiﬁcantly more potentiated by
approximately 2.5-fold in the gintonin-administered group when
compared with the vehicle-administered group (Figs. 2B, 2C,
n ¼ 10e12, p < 0.05). The control pathway remained unchanged
between groups (Figs. 2B, 2C, p > 0.5). These results indicated that
gintonin could contribute to enhance memory formation at the
cellular level, in agreement with our behavioral observations.
Interestingly, when brain slices was incubated in gintonin (3 mg/
mL in aCSF) for 1 h prior to recording fEPSPs, TBS induced only a
comparable amount of synaptic potentiation to vehicle incubation
(Fig. 3, p > 0.4 for amplitude; p > 0.9 for rise slope). This obser-
vation suggests that prolonged and acute LPAR activation via gin-
tonin bath application may have distinctive effects on synaptic
plasticity.
3.3. Gintonin increases the expression of memory-related proteins
in the hippocampus
Given that the chronic gintonin administration but not acute
gintonin incubation enhances LTP, gintonin-induced enhancement
of synaptic potentiation is anticipated to accompany changes in
gene expression levels. We examined whether prolonged gintonin
oral administration would alter the expression of CREB, a well-
characterized transcription factor, which can modulate the
expression of a number of learning and memory-related genes [14].
It is well known that phosphorylation of site by various protein
kinases initiates gene transcription, thereby leads to consolidation
of the memory [15,16]. Therefore, elevated phosphorylated-CREB
(p-CREB) is considered as a molecular marker of late LTP in the
hippocampus after learning [17]. We found that the p-CREB was
signiﬁcantly increased following fear learning in the gintonin-
administered mice when compared with vehicle-administered
mice (Fig. 4, p < 0.05). There was no difference in levels of CREB
between vehicle- and gintonin-administered groups (Fig. 4, p> 0.9).
Next, we investigated the expression level of BDNF after vehicle
or gintonin administration to examine whether increased p-CREB
Fig. 2. Oral administration of gintonin enhances long-term synaptic potentiation in the Shaffer collateral pathway. (A) Theta burst stimulations (TBS, 20 bursts of 4 pulses at 100 Hz)
were given at CA3-CA1 synapses from acutely prepared hippocampal slices after daily oral administration of vehicle or gintonin for 7 d (50 mg/kg). (B) In the gintonin-administered
group, both the rise slope (10e90%) and amplitude of the stimulated pathway were signiﬁcantly more potentiated than the vehicle-administered group (34% vs. 86% for rise slope,
*p < 0.05; 30% vs. 67% for amplitude, **p < 0.01, vehicle vs. gintonin group, respectively, n ¼ 7e17). The bar graph showed the fold change in rise slope and amplitude of 60 min after
LTP induction compared to baseline. (C) Stimulated pathways were signiﬁcantly potentiated after gintonin administration compared to control pathway (gintonin: rise slope,
**p < 0.01, amplitude, **p < 0.01, vehicle: rise slope, **p < 0.01, amplitude, *p < 0.05). The gray trace represents an averaged ﬁeld excitatory postsynaptic potentials (fEPSP) during
baseline (a) and the black trace represents an averaged fEPSP response 50e60 min after TBS stimulation (b) (scale bar: 20 ms and 0.2 mV). Error bars represent standard error of the
mean.
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primary target of CREB and learning increases BDNF expression
[18]. A decrease in BDNF was reported to disrupt learning and
memory formation [19]. Our results showed that the BDNF
expression was signiﬁcantly increased in gintonin-administered
mice when compared with vehicle-administered mice (Fig. 4,
p < 0.05), suggesting that prolonged systemic gintonin adminis-
tration caused an increase in the phosphorylation of CREB and
BDNF expression, which may contribute to enhance hippocampal-
dependent fear memory formation.
4. Discussion
In the current study, we have explored the effect of gintonin-
mediated LPAR activation on synaptic plasticity and
hippocampal-dependent memory task in adult mice. Chronic
administration of gintonin signiﬁcantly strengthened
hippocampal-dependent contextual fear memory retention and
augmented long-term synaptic potentiation in the Schaffercollateral pathway of the hippocampus. We found increased
expression of synaptic plasticity-related molecules after gintonin
administration. Our ﬁndings suggest that the prolonged oral de-
livery of gintonin could contribute to improve contextual memory
formation.
Previous studies using LPAR1-deﬁcient mice have shown that a
lack of LPAR1 causes impaired cognitive performances. For
instance, LPAR1 deﬁciency causes impairments in hippocampus-
dependent spatial memory test [4]. Genetic LPAR1 deﬁciency or a
blockade of LPAR1 with antagonists results in impaired fear
memory extinction [20]. Previous studies have shown that gintonin
activates LPARs in vitro and ex vivo preparations [5,6,8]. Therefore,
gintonin-mediated activation of LPAR was anticipated to improve
cognition. In line with this, when we examined the fear memory
retention using the contextual fear conditioning test, we found that
freezing behavior was remarkably increased upon prolonged gin-
tonin administration in DBA/2 mouse. Among strains of mice
available, DBA/2 mouse strain has been previously reported to
perform poorly in the contextual fear learning paradigm [10].
Fig. 3. Acute gintonin bath application has no effect on synaptic plasticity in the CA3-CA1 synapses. (A) Theta burst stimulations (TBS, 20 bursts of 4 pulses at 100 Hz, repeated twice
in 10 s) were given at Shaffer collateral pathway 1 h after gintonin or vehicle incubation (3 mg/mL). (B, C) Upon 1 h gintonin incubation, TBS-induced fold changes in both rise slope
(10e90%) and amplitude of the stimulated pathway (stim. path.) remained comparable with vehicle group (42% vs. 42% for rise slope , p > 0.9; 70% vs. 50%, for amplitude, p > 0.4,
vehicle (v) vs. gintonin (g) group, respectively, con.path.: control pathway, n ¼ 5e7). The gray trace represents an averaged ﬁeld excitatory postsynaptic potentials (fEPSP) during
baseline and the overlaid black trace represents an averaged fEPSP response 50e60 min after TBS stimulation (scale bar: 20 ms and 0.2 mV). Error bars represent standard error of
the mean.
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beta protein 1-42 release in the hippocampus in an animal model of
Alzheimer’s disease [13]. Our current observation provides further
support that gintonin’s memory-enhancing effect is not limited to
neurodegenerative conditions, thus allowing the extended appli-
cation of gintonin for healthy individuals with declined cognition.
Previously, we have shown that LPAR activation via gintonin
potentiates evoked synaptic transmission in the hippocampus ofFig. 4. Gintonin administration increases hippocampal cyclic adenosine monophosphate-res
(BDNF) expression. (A) Representative immunoblots of hippocampal CREB and phosphoryla
the contextual fear conditioning paradigm. Data are expressed as the ratio between p-CREB
compared with vehicle-administered mice (n ¼ 7e8, *p < 0.05). (C) Representative immuno
Overall hippocampal BDNF expression was signiﬁcantly higher in gintonin-administered m
represent standard error of the mean.juvenile animals [5]. However, the effect of gintonin on synaptic
efﬁcacy in the adult hippocampus has not been investigated so far.
Here, we assessed LTP in Schaffer collateral pathway, which ex-
presses N-methyl-D-aspartate receptor (NMDAR)-dependent
postsynaptic LTP [21]. Gintonin has been shown to work through
NMDAR activation [6]; it activates phospholipase C (PLC)/protein
kinase C (PKC) pathway, which is known to mediate LTP priming
and maintenance in hippocampal neurons [22]. In addition, it hasponse element binding (CREB) phosphorylation and brain-derived neurotrophic factor
ted CREB (p-CREB). (B) CREB and p-CREB levels were quantiﬁed 30 min after testing in
/CREB. There was a signiﬁcant increase in p-CREB in gintonin-administered mice when
blots of hippocampal BDNF. (D) Data are expressed as the ratio between BDNF/b-Actin.
ice when compared with vehicle-administered mice (n ¼ 7e8, *p < 0.05). Error bars
J Ginseng Res 2016;40:55e6160been suggested that the fear learning is strongly correlatedwith the
synaptic potentiation of the Schaffer collateral pathway [23].
Therefore, it is anticipated that gintonin-mediated chronic LPAR
activation would enhance synaptic potentiation of the CA1-CA3
synaptic circuitry.
When we examined how LPAR activation modulated the syn-
aptic plasticity in the Schaffer collateral pathway, a remarkable
enhancement in the potentiation of synaptic activity (w2.5-fold of
vehicle group) following 1 wk of daily gintonin administration was
observed. This observation suggests that chronic gintonin admin-
istration augmented LTP in the adult hippocampus. It has been
shown that a direct bilateral infusion of LPAs into rodent hippo-
campi activates Rho-dependent signaling pathways but not ERK-
dependent pathways, which results in improved performance in
the Morris water maze test [4]. The activation of Rho-dependent
signaling pathway contributes to LTP initiation, consolidation and
dendritic plasticity [24]. Gintonin is a strong LPAR-binding
component and we observed a signiﬁcant enhancement in LTP
following gintonin administration; therefore, it is possible that
gintonin-mediated LPAR activation might lead to Rho pathway
activation and thereby contribute to enhance LTP [24], although
this speculation needs further examination.
Interestingly, hippocampal LTP was enhanced only following
chronic systemic administration but not acute incubation of gin-
tonin, strongly suggesting that gintonin-mediated LPAR activation
could have two distinct mechanisms of action depending on
duration of activation. Finally, we explored molecular changes that
accompanied the improved fear memory and enhanced LTP. BDNF
is a neurotrophic factor that acts as key regulator of protein syn-
thesis required for LTP induction [25e27]. The interaction between
BDNF and tyrosine kinase receptor B (TrkB) triggers signalling
cascades that induce both a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR) and NMDAR trafﬁcking
in synapses [28]. In addition, BDNF increases postsynaptic density
protein 95 (PSD95), which is important for dendritic spine forma-
tion [29]. When BDNF is released from vesicles in an activity-
dependent manner, one of the primary targets of action is CREB
and associated kinases [30]. CREB is one of the well-studied tran-
scriptional factors that govern the expression of a series of synaptic
proteins in an activity-dependent manner [31,32]. We observed
that increased BDNF expression and CREB phosphorylation were
accompanied by prolonged systemic LPAR activation. It still re-
mains to be investigated whether the activation of LPARs may
directly stimulate the release of BDNF or the phosphorylation of
CREB in the hippocampus.
Our study has analyzed synaptic and molecular changes occur-
ring in the hippocampus; however, prolonged LPAR activation may
affect other brain structures. LPAR signaling cascades have been
implicated in different aspects of cognition beyond hippocampus-
dependent memory. For example, LPAR1-deﬁcient mice have sig-
niﬁcant deﬁcits in prepulse inhibition, which is found in patients
with schizophrenia [33]. In addition, the amygdala of LPAR1-
deﬁcient mice was reported to express higher c-fos upon expo-
sure to acute stressors [20]. These studies suggest that the action of
gintonin is not limited to the hippocampus, implying that the
chronic activation of LPARs may modulate other behaviors,
including emotional behaviors. Further investigations may reveal
additional sites of action for gintonin and gintonin-dependent
behavioral modulations.
In summary, our study suggests that systemic gintonin admin-
istration enhances the capacity of synaptic plasticity in the mature
hippocampus and signiﬁcantly improves fear memory formation.
We have shown that enhanced LTP and improved cognitive per-
formances were accompanied by an increase in BDNF expression
and phosphorylation of CREB protein. Therefore, the activation ofLPARs could be a useful target for alleviating memory impairments
and cognitive deﬁcits in patients with neurodegenerative diseases
in addition to healthy aged people.
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